You are here

Article info

Article menu
Download PDFPDF
Basic and translational research
Concise report
The type I IFN signature as a biomarker of preclinical rheumatoid arthritis

Authors

  1. Correspondence to Dr Cornelis L Verweij, Department of Pathology and Rheumatology, VU University Medical Center, Section of Inflammatory Disease Profiling, CCA2.28, P.O. box 7075, Amsterdam 1007 MB, The Netherlands; c.verweij{at}vumc.nl
View Full Text

Citation

Lübbers J, Brink M, van de Stadt LA, et al
The type I IFN signature as a biomarker of preclinical rheumatoid arthritis
Annals of the Rheumatic Diseases 2013;72:776-780.

Publication history

  • Received September 29, 2012
  • Revised December 24, 2012
  • Accepted February 3, 2013
  • First published February 23, 2013.
Online issue publication 
July 11, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions